Total Payments
$9,010
2024 Payments
$5,324
Companies
16
Transactions
169
Medicare Patients
1,534
Medicare Billing
$162,072
Payment Breakdown by Category
Consulting$5,250 (58.3%)
Food & Beverage$3,693 (41.0%)
Travel$67.16 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,250 | 2 | 58.3% |
| Food and Beverage | $3,693 | 162 | 41.0% |
| Travel and Lodging | $67.16 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $3,546 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,335 | 21 | $0 (2024) |
| ABBVIE INC. | $1,028 | 48 | $0 (2024) |
| Amgen Inc. | $616.21 | 30 | $0 (2024) |
| Dermavant Sciences, Inc. | $515.64 | 23 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $226.11 | 10 | $0 (2024) |
| PFIZER INC. | $218.91 | 11 | $0 (2024) |
| GENZYME CORPORATION | $203.77 | 4 | $0 (2024) |
| Galderma Laboratories, L.P. | $92.45 | 1 | $0 (2024) |
| Blueprint Medicines Corporation | $55.36 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,324 | 87 | UCB, Inc. ($3,546) |
| 2023 | $1,283 | 66 | ABBVIE INC. ($282.54) |
| 2022 | $126.05 | 5 | ABBVIE INC. ($65.76) |
| 2021 | $43.01 | 2 | Amgen Inc. ($23.81) |
| 2020 | $2,015 | 2 | E.R. Squibb & Sons, L.L.C. ($2,000) |
| 2019 | $219.58 | 7 | AbbVie, Inc. ($219.58) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.28 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Inflammation | ||||||
| 10/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $32.18 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.54 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: DERMATOLOGY | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $92.45 | General |
| Category: ACNE | ||||||
| 08/30/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $23.18 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,269 | 2,176 | $358,336 | $131,596 |
| 2022 | 10 | 265 | 364 | $62,579 | $30,476 |
Total Patients
1,534
Total Services
2,540
Medicare Billing
$162,072
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 284 | 354 | $67,800 | $26,059 | 38.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 51 | 63 | $39,395 | $16,967 | 43.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 83 | 113 | $49,428 | $16,544 | 33.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 145 | 172 | $33,110 | $13,991 | 42.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 101 | 124 | $29,059 | $12,074 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 112 | $27,529 | $10,924 | 39.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 153 | 181 | $27,395 | $7,702 | 28.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 42 | 50 | $25,492 | $5,180 | 20.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 121 | 757 | $18,738 | $4,561 | 24.3% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 12 | 14 | $7,400 | $4,292 | 58.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 52 | 94 | $9,205 | $4,093 | 44.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $10,939 | $4,029 | 36.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 52 | $4,776 | $2,378 | 49.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,886 | $2,331 | 39.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 12 | $1,704 | $460.50 | 27.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 13 | $480.00 | $11.36 | 2.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 24 | 29 | $13,572 | $8,007 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 51 | $7,650 | $3,772 | 49.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 20 | 22 | $8,404 | $3,373 | 40.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 34 | 36 | $5,040 | $3,202 | 63.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $5,000 | $2,764 | 55.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 17 | 22 | $7,788 | $2,539 | 32.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 20 | 24 | $4,200 | $2,395 | 57.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 38 | 39 | $4,875 | $2,058 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,600 | $1,754 | 48.7% |
About Dr. Joseph Kamel, DO
Dr. Joseph Kamel, DO is a Dermatology healthcare provider based in Aliso Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1003304759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Kamel, DO has received a total of $9,010 in payments from pharmaceutical and medical device companies, with $5,324 received in 2024. These payments were reported across 169 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($5,250).
As a Medicare-enrolled provider, Kamel has provided services to 1,534 Medicare beneficiaries, totaling 2,540 services with total Medicare billing of $162,072. Data is available for 2 years (2022–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Aliso Viejo, CA
- Active Since 04/27/2018
- Last Updated 11/16/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1003304759
Products in Payments
- Bimzelx (Biological) $3,546
- SKYRIZI (Biological) $784.22
- Otezla (Drug) $616.21
- VTAMA (Drug) $515.64
- DUPIXENT (Biological) $399.89
- Sotyktu (Drug) $303.84
- EUCRISA (Drug) $218.91
- Skyrizi (Biological) $130.23
- AKLIEF (Drug) $92.45
- Humira (Biological) $89.35
- AYVAKIT (Drug) $55.36
- CAPLYTA (Drug) $44.96
- YCANTH (Drug) $43.23
- LIBTAYO (Biological) $29.99
- ADBRY (Biological) $26.12
- Winlevi (Drug) $24.66
- RINVOQ (Biological) $24.16
- COSENTYX (Drug) $17.07
- Zoryve (Drug) $16.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.